Population pharmacokinetics of peginterferon α2a in patients with chronic hepatitis B


There were significant differences in response and pharmacokinetic characteristics to the peginterferon α2a treatment among Chronic Hepatitis B (CHB) patients. The aim of this study is to identify factors which could significantly impact the peginterferon α2a pharmacokinetic characteristics in CHB patients. There were 208 blood samples collected from 178… (More)
DOI: 10.1038/s41598-017-08205-5


  • Presentations referencing similar topics